y p o c t
play

Y P O C T Safety & Guidelines for tDCS O N O Felipe - PowerPoint PPT Presentation

Y P O C T Safety & Guidelines for tDCS O N O Felipe Fregni, MD, PhD D Spaulding Neuromodulation Center Spaulding Rehabilitation Hospital & Massachusetts General Hospital Harvard Medical School Y P O C T O N O D Is tDCS


  1. Y P O C T Safety & Guidelines for tDCS O N O Felipe Fregni, MD, PhD D Spaulding Neuromodulation Center Spaulding Rehabilitation Hospital & Massachusetts General Hospital Harvard Medical School

  2. Y P O C T O N O D

  3. Is tDCS Safe? Y P O C T O N O D The FDA has not approved tDCS as a therapy or approved ANY device for tDCS.

  4. Y P O C T Risks to Subjects O N O D

  5. Theoretical Risks (1): skin Y P • Potential Effects O C – Electrolysis, Permeability Changes, Increased Metabolic Activity, Seizure? T • Burn O • Stimulating subjects with: N – Reduced Sensation O – Broken Skin D – Conductive Implants – Tumor – Concurrent Pharmacological Treatments

  6. Tissue heating Y P O • Animal study – C T Liebetanz et al, 2009 O N O D

  7. Skin burn/dermatitis Y P O Skin lesion: C “The anodal electrode was T fixed by an O EEG cap. Two mA stimulation N current was applied for 26 min, including O 30 s ramp in D and 30 s ramp out.” Healthy subject – single session (Wang, 2015)

  8. Skin lesion (2) Y P O C Patient – several sessions (4/5) – 1mA T over 20 minutes. O (Palm, 2008) N O D

  9. Contact dermatitis Y P O Healthy subject: C Single session, symptoms appeared after 24 hs of T stimulation and got worse. (Kaubish, 2012) O N O D

  10. Y P O How about if a subject has C T a skull defect? O N O D

  11. Current Distribution in tDCS Y P O C T O N O D Datta et. al., 2009 • Wagner et al., 2007 •

  12. Skull Y defect P O C T O N O D

  13. Y P O C T O N O D Datta, 2010

  14. Y P O C T Other Adverse Effects O N O D

  15. Adverse Effect Reports Y P • Brunoni et al., 2011 – Systematically reviewed O reports of AE ’ s in human studies of patients and healthy subjects. C – 172 articles (209 studies) included T – 117 studies assessed AE ’ s O – 74 studies reported at least 1 AE • Findings for Active Stimulation: N – Most commonly reported effects are mild O – Itching (39.3%) – Tingling (22.2%) D – Headache (14.8%) – Burning sensation (8.7%) – Discomfort (10.4%)

  16. Y P O C T Device O N O D

  17. Device Safety Features Y P • Automatic Current Ramping O • Impedance Check C • Display of Actual Current T O • Soterix Medical Device N – SMARTscan – “ Relax ” Slider O – “ Tickle ” Button D – Low Battery Light

  18. Cables Y P O C T O N O D

  19. Practical Safety Considerations Y P • Hair O • Excess Water Run-off C • Old/Dried out sponges T • Broken Electrodes O • Rusting of Equipment N • Battery Charge O • Current Fluctuation During Stimulation D • Current Spiking During Device On/Off

  20. Safety Recommendations Y P O • Screening for exclusion criteria C • Keep informed of new safety guidelines T • Consider specific device O • Obtain IRB approval N • Consider environment for stimulation (ex. O D Hospital/University) • Have emergency procedures prepared

  21. Y P O C T O N Thank You O D

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend